Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Growing demand for point of care testing
3.2.1.3 Technological advancements in the products
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, 2023
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Strip
5.3 Cassette
5.4 Test panel
5.5 Midstream
5.6 Dip card
5.7 Other product types
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Infectious disease
6.3 Diabetes & glucose
6.4 HIV
6.5 Pregnancy
6.6 Cholesterol & triglycerides
6.7 Urinary tract infection
6.8 Other test types
Chapter 7 Market Estimates and Forecast, By Sample, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Other samples
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Retail pharmacies
8.3 Hospital pharmacies
8.4 Online pharmacies
8.5 Other distribution channels
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott
10.2 ACON Laboratories, Inc.
10.3 Ascensia Diabetes Care Holdings AG
10.4 BD
10.5 bioLytical Laboratories Inc.
10.6 BioSure
10.7 Cardinal Health
10.8 Chembio Diagnostics, Inc
10.9 F. Hoffmann-La Roche Ltd.
10.10 LifeScan IP Holdings, LLC
10.11 MP BIOMEDICALS
10.12 Nova Biomedical
10.13 OraSure Technologies, Inc.
10.14 Quidel Corp.
10.15 SA Scientific Ltd
10.16 Siemens Healthcare GmbH
10.17 Sterilab Services
